About All Cure Pharma
All Cure Pharma is a Healthcare company based in Delhi (India) by Shiv Dutt Sharma and Nirankar Sharma. It manufactures allergens for diagnosis and immunotherapy to treat environmental allergies. It operates on a B2B model. Its Indian entity All-Cure Pharma Private Limited reported revenue of ₹3.65 Cr. All Cure Pharma offers products and services including Allergens for Diagnosis and Allergens for Immunotherapy. Its focus areas include Pharmaceuticals, Allergy Treatment and Immunotherapy.
Company details
All Cure Pharma Pvt. Ltd. specializes in manufacturing a wide range of allergens for both diagnosis and immunotherapy, aiming to alleviate allergy symptoms through graded exposure treatments. The company operates from its office in New Delhi and factory in Bahadurgarh, Haryana, supplying products to medical professionals. It focuses on quality and reliability in the allergy treatment sector, offering diverse allergens to address common environmental triggers like pollens and dust mites.
- Headquarters Delhi, India
- Founders Shiv Dutt Sharma, Nirankar Sharma
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website allcurepharma.in
- Legal Name All-Cure Pharma Private Limited
- Date of Incorporation 19 Oct, 1994
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹3.65 Cr
FY 2024 · +5% YoY
- Net Profit₹5.8 Lakh
FY 2024 · 2% margin
- EBITDA₹13.1 Lakh
FY 2024 · 4% margin
Associated legal entities of All Cure Pharma
All Cure Pharma operates through All-Cure Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| All-Cure Pharma Private Limited CIN U74899DL1994PTC062225 | Active | 19 Oct 1994 | New Delhi, Delhi | ₹3.7 Cr | 3 | View details |
Products & Services of All Cure Pharma
All Cure Pharma offers a comprehensive portfolio of products and services, including Allergens for Diagnosis and Allergens for Immunotherapy.
Products used to identify allergies through immune response testing
Substances for desensitizing patients to allergens via gradual exposure
Board of directors of All-Cure Pharma Private Limited (All Cure Pharma)
All-Cure Pharma Private Limited is the primary company behind All Cure Pharma. The board of All-Cure Pharma Private Limited currently have 3 directors; the longest-serving is Jitender Kumar Sharma, appointed in 1994. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jitender Kumar Sharma DIN 01207745 | Director | 19 Oct 1994 | 32 yrs | All-Cure Pharma Private Limited |
| Shiv Dutt Sharma DIN 02436211 | Director | 01 Jan 2015 | 11 yrs 9 mo | All-Cure Pharma Private Limited |
| Manoj Kumar Sharma DIN 09480954 | Managing Director | 30 Dec 2021 | 4 yrs 9 mo | All-Cure Pharma Private Limited |
People of All Cure Pharma
2 people are tracked at All Cure Pharma (2 in leadership).
| Name | Role | Group |
|---|---|---|
| ex-Co-Founder | Leadership | |
| ex-Co-Founder | Leadership |
Complete people profiles for All Cure Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of All Cure Pharma
Figures of All-Cure Pharma Private Limited, the primary company behind All Cure Pharma, for FY 2024. Revenue was ₹3.65 Cr (+5% year on year). Net profit was ₹5.8 Lakh (2% margin). EBITDA was ₹13.1 Lakh (4% margin). Revenue has grown at a compounded annual rate of +15% over three years and +4% over five years.
- ₹3.65 CrRevenue · FY 2024 · +5% YoY
- ₹5.8 LakhNet profit · 2% margin
- ₹13.1 LakhEBITDA · 4% margin
- ₹9.6 LakhPaid-up capital
- +15%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of All-Cure Pharma Private Limited are on its company page.
Detailed financial statements for All Cure Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about All Cure Pharma
All Cure Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind All Cure Pharma, All-Cure Pharma Private Limited, reported revenue of ₹3.65 Cr for FY 2024, up 5% year on year.
All Cure Pharma Pvt. Ltd. specializes in manufacturing a wide range of allergens for both diagnosis and immunotherapy, aiming to alleviate allergy symptoms through graded exposure treatments. The company operates from its office in New Delhi and factory in Bahadurgarh, Haryana, supplying products to medical professionals. It focuses on quality and reliability in the allergy treatment sector, offering diverse allergens to address common environmental triggers like pollens and dust mites.
All Cure Pharma offers Allergens for Diagnosis and Allergens for Immunotherapy.
All Cure Pharma operates through All-Cure Pharma Private Limited.
The legal entities of All Cure Pharma currently have 3 directors, including Manoj Kumar Sharma, Shiv Dutt Sharma, Jitender Kumar Sharma.